𝔖 Bobbio Scriptorium

✦ LIBER ✦

PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs

✍ Scribed by Weigelt, B; Warne, P H; Downward, J

Book ID: 109972894
Publisher: Nature Publishing Group
Year: 2011
Tongue: English
Weight: 818 KB
Volume: 30
Category: Article
ISSN: 0950-9232
DOI: 10.1038/onc.2011.42

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The predictive role of phosphatase and t

The predictive role of phosphatase and tensin homolog (PTEN) loss, phosphoinositol-3 (PI3) kinase (PIK3CA) mutation, and PI3K pathway activation in sensitivity to trastuzumab in HER2-positive breast cancer: a meta-analysis

✍ Wang, Yaohui; Liu, Yu; Du, Yueyao; Yin, Wenjin; Lu, Jinsong 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 485 KB

Oncogenic PIK3CA gene mutations and HER2

Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2)

✍ English, Diana P.; Bellone, Stefania; Cocco, Emiliano; Bortolomai, Ileana; Pecor 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 806 KB